| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |